Pipeline: Pediatric Scalds

EXPLORING POTENTIAL APPLICATION IN PEDIATRIC SCALD WOUNDS

A scald is damage to the skin caused by a wet heat, such as boiling water or steam. In the U.S., it is estimated that 30% of burn patients are within the ages of one to 15 years old, and approximately 45% of the pediatric burn injuries are from scald burns.[1]

Ongoing research with the RECELL® System for the treatment of pediatric scald wounds help share experiences among the medical community. Below is a case study provided as background. For general information about our science and technology, please contact our Medical Affairs team.

CASE STUDY: PEDIATRIC SCALD

Two-year-old Zed spilled a hot cup of tea over himself which left him with a severe scald. Following treatment with the RECELL® System, which utilized Zed’s own skin to develop Spray-On Skin™ Cells, the toddler fully recovered and within approximately four months the scars were barely visible.

Pediatric Scald Before Treatment

BEFORE TREATMENT

Pediatric Scald 10 Weeks Post Treatment with RECELL

10 WEEKS
POST-RECELL® TREATMENT


ADDITIONAL RESEARCH: ABSTRACTS, POSTERS, PUBLICATIONS

  • Nanassy et al. The Use of an Autologous Cell Harvesting and Processing Device to Decrease Surgical Procedures and Expedite Healing in Two Pediatric Burn Patients. Wounds. 2019 Dec;31(12):316-321
    https://pubmed.ncbi.nlm.nih.gov/31833837/
  • Presentation: J Carter. Evaluation of Pediatric Population Treated for Burn Injuries Using an Autologous Skin Cell Suspension. 2019 April 2-5; American Burn Association; Las Vegas, NV.
  • Poster: P Glat. The Use of an Autologous Cell Harvesting and Processing Device in Two Burn Patients at an Urban Pediatric Burn Center. 2018 November 9-10; Northeast Region Burn Conference; Cambridge, MA.
  • Presentation: A Bairagi. Autologous skin cell suspensions and partial thickness paediatric burns: The BRACS Trial Protocol. 2018 October 16-19; Australian & New Zealand Burn Association Annual Scientific Meeting; Brisbane, Australia.
  • Poster: P Glat. The Use of of ReCell in a Pediatric Burn Patient at an Urban Burn Center. 2017 October 12-13; Eastern Great Lakes Region Burn Conference; Rochester, NY.
  • Wallace et. al. Burns & Trauma. Identification of factors predicting scar outcome after burn injury in children: a prospective case-control study. 2017; 5:19
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5494810/
  • Wood et. al. Burns. A prospective randomised clinical pilot study to compare the effectiveness of Biobrane® synthetic wound dressing, with or without autologous cell suspension, to the local standard treatment regimen in paediatric scald injuries. 2012;38(6):830-9
    https://pubmed.ncbi.nlm.nih.gov/22322141/
  • Dunne et. al. Burns. Early paediatric scald surgery – A cost effective dermal preserving surgical protocol for all childhood scalds. 2014;40(4):772-778
    https://pubmed.ncbi.nlm.nih.gov/24333011/

Caution: The safety and effectiveness of RECELL® have not been established for acute thermal partial-thickness or full-thickness burn wounds in pediatric patients younger than 18 years of age.

The RECELL® System is approved by the U.S. Food and Drug Administration (FDA) for the treatment of acute thermal burns in patients 18 years and older. Click here for Important Safety Information and Instructions for Use.


  1. American Burn Association NBR Advisory Committee, National Burn Repository 2016 Report
This website stores cookies on your computer. These cookies are used to improve your website experience and provide more personalized services to you, both on this website and through other media. To find out more about the cookies we use, see our privacy policy.